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ing. It is known that trisomy 21, or Down syndrome, causes numerous clinical
manifestations including premature aging. The authors used fibroblast lines with
one, two, and three copies of chromosome 21 to look for differential protein syn-
thesis possibly related to the genedosage. An excellent theoretical analysis ofprotein
changes with aging is included in this work as well.
The nineteen papers which comprise this volume are very intelligently presented.
While the data per se is not new, the strong organization and excellent experimental
approaches and theoretical discussions make this book an excellent resource for
those studying gene expression, differentiation, and tumor biology.
DAVID A. FRANK
Medical Student
Yale University School ofMedicine
MULTIPLE SCLEROSIS. A GUIDE FOR PATIENTS AND THEIR FAMILIES. Edited by Labe
C. Scheinberg. New York, Raven Press, 1983. 253 pp. $9.50. Paperbound.
As its title indicates, this book is a guide for multiple sclerosis patients and their
families. Scheinberg, the editor, more explicitly states the purpose ofthe book in his
introduction: "It is intended to be a guide on ways to adapt to an unpredictable ill-
ness and to lead a long and productive life in spite of it." Many aspects of multiple
sclerosis are covered, ranging from diagnosis, signs and symptoms, and available
treatments of the disease, to sexual, psychological, and social changes multiple
sclerosis patients must face. These topics are explored in sixteen chapters written by
different authors, including neurologists, psychiatrists, nurses, and social workers.
Each author offers insight into his particular field, but some chapters are much
clearer and more informative than others-a problem which careful editing could
have overcome.
The best chapters include those on sexuality, bladder and bowel function, and
aids to ease daily living, with each offering practical advice on what changes to ex-
pect and how best to cope with them. The chapter on aids to ease the activities of
daily living is quite detailed, as its authors discuss what type ofwheelchair is best (if
one is needed), which kitchen arrangement allows for the least amount of move-
ment, where grab-bars are handy, and so on. The chapters on bowel and bladder
management and on sexuality are helpful in a different way, as they explore subjects
which the multiple sclerosis patient might have difficulty discussing with family,
friends, or physician. With 80-90 percent of multiple sclerosis patients reporting
changes in their sexual lives and as many as 80 percent developing urinary symp-
toms, these areas are clearly of great import to the patient.
Unfortunately, all the chapters are not as good as the three cited above. The
chapter on diet is particularly weak, as the author lists several diets but makes no
comments on the effectiveness or ineffectiveness of them. Another poor chapter is
that on signs, symptoms, and course of the disease, since it repeats information
given in two earlier chapters. Inconsistent editing and organization also detract from
the value of this book. The person used switches within and between chapters from
"he" to "he or she" to "h/she" to "you," which can be somewhat annoying to the
reader. Another problem is the format ofeach chapter, some ending with a"Conclu-
sion," others with a "Discussion," others with a "Summary," and still others with no
wrap-up at all. With the exception of one chapter, there are no references or
bibliographies. There is a general reading list at the end of the book, but this wouldBOOK REVIEWS 255
be oflittle help to the reader interested in learning more about a particular aspect of
the disease.
In spite of these shortcomings, however, this book could be of use to the patient
with multiple sclerosis. Practical advice for coping with everyday problems and
frank discussion of "touchy" subjects could be invaluable to the patient who feels
overwhelmed by the disease.
CATHARINE ARNOLD
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CEREBROVASCULAR DISEASES. THIRTEENTH RESEARCH (PRINCETON) CONFERENCE.
Edited by Martin Reivich and Howard I. Hurtig. New York, Raven Press, 1983.
437 pp. $73.00.
This book is a compilation of papers presented at the Thirteenth Research Con-
ference on Cerebrovascular Disease held at Williamsburg, Virginia, from February
28 to March 2, 1982. It was sponsored by the American Neurological Association
and the American Heart Association, Stroke Council. An international panel of
participants from North America and Europe composed of research scientists and
clinicians-neurologists, neurosurgeons, pathologists, pharmacologists, epidemiol-
ogists, and others-took part in the conference.
Both basic research and clinical papers are presented. The initial portion of the
book contains a brief overview of the mechanism of NMR, as well as present and
potential uses of NMR and PET scanning in cerebrovascular disease. Both modali-
ties represent potential quantum leaps in research and clinical management ofstroke
patients. PET scanning appears to be the current test of choice for evaluation of
cerebral tissue blood flow and metabolism. Abstracts ofsome ofthe discussions that
followed the presentations are presented throughout the book and are, in general,
quite pertinent. For example, the discussion concerning the potential dangers of
metallic objects-notably ferromagnetic-on or in the body of a patient undergoing
an NMR scan is of interest and clinically significant.
The second major section of this book deals with prognostic indicators in cere-
brovascular disease. Many of these articles contain important clinical implications.
Some of the more notable presentations merit brief mention. The significant de-
crease in stroke mortality, especially over the past 15 years, is felt to be a direct result
ofimproved therapy ofheart disease and hypertension. A most interesting article by
Norris and D'Alton concludes that current published data on surgical versus con-
servative management of the asymptomatic carotid bruit is inadequate to decide on
correct therapeutic management. Age, hypertension, heart disease, and diabetes are
noted as the most important risk factors in both transient ischemic attacks (TIAs)
and stroke. Another presentation notesthat there is no clear-cut evidence asto which
ofvarious treatment modalities is superior for acute cerebral infarction in evolution.
Four factors which were seen as clinical predictors ofstroke severity in a prospective
study at the New York Hospital were: (1) degree of focal neurological deficit, (2)
level of sensorium, (3) decrease in brain density on CT scan, and (4) blood sugar
level on hospital admission. Location and type of stroke also correlate with the se-
verity of residual deficits, and post-stroke affective disorders are common, espe-
cially depression. A comparative review of the results of therapy for subarachnoid